Substance / Medication

Lercanidipine

Overview

Active Ingredient
lercanidipine
RxNorm CUI
135056

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Rizzoni Damiano · Curr Med Res Opin · 2016
PMID: 27779457Meta-Analysis
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.
Hanauer Schaab Estela, Lanchote Vera Lucia, Balthazar Nardotto Glauco Henrique et al. · J Clin Pharmacol · 2020
PMID: 31353479RCT
Lercanidipine effect on circulating CD34+ progenitor cells in elderly patients: a randomized study.
Peixiao Shen, Ningyuan Fang, Haiya Wang · Curr Med Res Opin · 2016
PMID: 27779456RCT
Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake.
Álvarez Covadonga, Gómez Estrella, Simón Marta et al. · Eur J Clin Pharmacol · 2012
PMID: 22294059RCT
Superior palatability of crushed lercanidipine compared with amlodipine among children.
Milani Gregorio, Ragazzi Monica, Simonetti Giacomo D et al. · Br J Clin Pharmacol · 2010
PMID: 20233185RCTFull text (PMC)
Comparison of changes of body water measured by using bioelectrical impedance analysis between lercanidipine and amlodipine therapy in hypertensive outpatients.
Sansanayudh Nakarin, Wongwiwatthananukit Supakit, Veerayuthvilai Siriluck · J Med Assoc Thai · 2010
PMID: 21280519RCT
Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers.
Boralli Vanessa Bergamin, Coelho Eduardo Barbosa, Sampaio Stefânia Amaral et al. · J Clin Pharmacol · 2009
PMID: 19033449RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lercanidipine (substance)
SNOMED CT
395986007
UMLS CUI
C0526399
RxNorm CUI
135056

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.